Recent Finacing
Recent Raise
Nitric BioTherapeutics develops an iontophoresis drug‑delivery platform and topical nitric oxide therapies to treat onychomycosis, nongenital warts, tinea pedis, and skin/soft tissue infections; conducting Phase 2 trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors